Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
BioLargo develops and sells clean technology and life science products for water treatment, odor control, and medical devices.
BioLargo is a small cleantech and life sciences company that sells practical solutions for some surprisingly unglamorous problems: smell, dirty water, and wounds that will not heal. Its customers are mostly businesses, municipalities, and healthcare providers who need to handle waste, control odors, or improve medical care without spending a fortune.
One of its main products is a cup-sized device called the Pooph Pet Odor Eliminator, sold to everyday pet owners through retail channels, alongside a broader odor-control technology used in industrial and commercial settings. BioLargo also sells water treatment systems built around its own chemistry, which helps remove contaminants and clean up industrial wastewater. The company's life sciences arm develops wound-care products, including a treatment for chronic wounds that has drawn interest from the medical community.
What makes BioLargo interesting — and risky — is that it is a tiny, early-stage company with big ambitions. It holds a large portfolio of patents and has spent years developing technologies that could be worth a lot if they catch on, but its revenue is small and it has historically lost money while funding development. Investors who buy the stock are essentially betting that one or more of these products will break through commercially. The company has raised money through stock sales to keep going, which means its shares are exposed to dilution over time. In short, BioLargo is a lottery-ticket-style small cap: real technology, real products, but a long road to consistent profits.
Saved answer · last researched 16 Nov 2026